Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Mindset Pharma collaborates with CAMH on preclinical evaluation of MSP-1014

June 23, 2022

Data in mice support potential of ATL-1102 for limb girdle muscular dystrophy R2

June 23, 2022

A novel Smad4-mutated mouse model of Myhre Syndrome

June 23, 2022

Katholieke Universiteit Leuven describes new TRPM3 antagonists

June 23, 2022

Lenire licenses VSN-16R from UCL for fragile X syndrome

June 20, 2022

Merck & Co. patents orexin OX2 receptor agonists

June 16, 2022

Vanderbilt University patents new muscarinic M4 receptor antagonists

June 15, 2022

Alpha Cognition announces discovery of GEM combinations ALPHA-0702 and ALPHA-0802

June 14, 2022

Astrocyte-specific IL-2 delivery shows neuroprotective effect in four neuroinflammation models

June 14, 2022

Circuit, synuclein insights reported in Parkinson's disease

June 10, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...